Enzo Life Sciences PROTEOSTAT Aggresome Detection Kit

Tuesday, 14 November, 2017 | Supplied by: Sapphire Bioscience

Enzo Life Sciences’ PROTEOSTAT Aggresome Detection Kit provides a rapid, specific and quantitative approach to identifying inhibitors relevant to neurodegenerative disease in a cellular context. The kit is suitable for screening compounds of potential therapeutic value, and optimised for antibody co-localisation studies to identify interactions between aggregated protein cargo and the various proteins implicated in autophagy and aggresome formation.

The kit includes a simple assay that does not require non-physiological protein mutations or genetically engineered cell lines. It easily quantifies aggresome and related inclusion bodies by flow cytometry.

The product has been validated under a wide range of conditions and with small molecule modulators. It is particularly useful for the study of neurodegenerative diseases, liver disease, toxicology studies and more.

Online: www.sapphirebioscience.com
Phone: 02 9698 2022
Related Products

Bio-Rad IncRNA Workflow

Bio-Rad Laboratories has announced the IncRNA Workflow, a RT-qPCR workflow that is optimised for...

Cayman Chemical PAD4 Inhibitor Screening Assay Kit (Ammonia)

Cayman Chemical's PAD4 Inhibitor Screening Assay Kit (Ammonia) provides a convenient method...

Key Diagnostics RapidChek Listeria monocytogenes detection kit

Key Diagnostics is expanding its RapidChek testing solutions portfolio to include a system that...

  • All content Copyright © 2018 Westwick-Farrow Pty Ltd